Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
biochemistry, genetics and molecular biology
A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancer
Human Mutation, Volume 26, No. 4, Year 2005
Notification
URL copied to clipboard!
Description
The hormonal etiology of breast cancer is well-established. Many studies have assessed whether polymorphisms in steroid hormone metabolism genes are associated with breast cancer risk. We measured the CYPl7A1 -34T>C (c.-34T>C) promoter polymorphism in a population-based study of 1,404 Australian women with breast cancer diagnosed before age 60 years (case probands), 1,903 relatives, and 788 controls. Within-family analyses suggested the CC genotype was associated with, on average, a small increased risk. This finding appeared to be influenced by the families of three early-onset case probands with multiple affected sisters. CYP17A1 mutation screening revealed a case proband diagnosed at age 38 years who had a germline protein-truncating mutation (c.775C>T, p.Arg239X), which results in a nonfunctional enzyme and has been reported in a male compound heterozygote with 17 α-hydroxylase deficiency. This mutation was carried by both sisters diagnosed with breast cancer at ages 34 and 42 years, but not by a 57-year-old unaffected sister. It was not found in any of the other tested case probands (48 with multiple-affected relatives and 241 randomly selected) or controls. This study suggests there may be rare mutations in steroid hormone metabolism genes associated with a high dominantly-inherited breast cancer risk, and demonstrates how "high-risk susceptibility genes" might be discovered using population-based case-control-family studies. ©2005 Wiley-Liss, Inc.
Authors & Co-Authors
Hopper, John Llewelyn
Australia, Melbourne
University of Melbourne
Hayes, Vanessa M.
Australia, Sydney
Garvan Institute of Medical Research
Spurdle, Amanda B.
Australia, Brisbane
Qimr Berghofer Medical Research Institute
Chenevix-Trench, Georgia
Australia, Brisbane
Qimr Berghofer Medical Research Institute
Jenkins, Mark Andrew
Australia, Melbourne
University of Melbourne
Milne, Roger L.
Australia, Melbourne
University of Melbourne
Dite, Gillian S.
Australia, Melbourne
University of Melbourne
Tesoriero, Andrea A.
Australia, Melbourne
University of Melbourne
Giles, Graham G.
Australia, Melbourne
Cancer Council
Southey, Melissa Caroline
Australia, Melbourne
University of Melbourne
France, Lyon
Centre International de Recherche Sur le Cancer
Statistics
Citations: 11
Authors: 10
Affiliations: 6
Identifiers
Doi:
10.1002/humu.20237
ISSN:
10597794
Research Areas
Cancer
Genetics And Genomics
Study Design
Cross Sectional Study
Case-Control Study
Participants Gender
Male
Female